Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

11.65 +0.19 (+1.66%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 690,639
Open 11.63
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 11.46
Today's Range 11.55 - 11.67
52wk Range 11.43 - 17.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs 
Via InvestorPlace
AI To Revolutionize Clinical Trials And Diagnostics
With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-10.52%
-10.52%
1 Month
-14.59%
-14.59%
3 Month
-14.65%
-14.65%
6 Month
-27.59%
-27.59%
1 Year
-0.97%
-0.97%

More News

Read More
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Via Benzinga
Exposures Product Safety
Daily Stock Analysis: Bayer AG - May '23 Update
Via Talk Markets
Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
Via Benzinga
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Via Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
Via Benzinga
Exposures Product Safety
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
Via Benzinga
Regeneron Pharma Says Fewer Aflibercept Injections Maintains Vision, Anatomic Improvements In Diabetic Macular Edema
Via Benzinga
Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment
Via Benzinga
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
Via Benzinga
Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
Via Benzinga
Experimental Stem Cell Therapy For Parkinson's Shows Promise in Phase I Trial: Reuters
Via Benzinga
Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender
Via Investor's Business Daily
Unmasking Q2 2023's Stars & Strugglers: Industry ETFs And Top Stock Standouts
Via Benzinga
Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst
Via Benzinga
There’s Only One Way To Beat The Market
Via Talk Markets
Perrigo Picks Former Bayer Executive As New CEO
Via Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Via Talk Markets
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Via Benzinga
After That Big Merger, What Happened?
Via Talk Markets
InvestorNewsBreaks – ROTH MKM’s Agribusiness Investment Banking Group Serves as Sellside Advisor for Three M&A Transactions
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories
Via Benzinga
US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.